Reply to Laura Evangelista and Egesta Lopci’s Letter to the Editor re: Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327–9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2021.
All research outputs
#17,852,387
of 27,790,740 outputs
Outputs from European Urology
#5,835
of 6,950 outputs
Outputs of similar age
#255,431
of 461,650 outputs
Outputs of similar age from European Urology
#80
of 100 outputs
Altmetric has tracked 27,790,740 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,950 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.3. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 461,650 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
